Bristol-Myers Squibb Co (NYSE:BMY)
$ 44.94 0.2 (0.45%) Market Cap: 91.10 Bil Enterprise Value: 138.84 Bil PE Ratio: 0 PB Ratio: 5.52 GF Score: 82/100

Bristol-Myers Squibb Co at JPMorgan Healthcare Conference Transcript

Jan 13, 2020 / 03:30PM GMT
Release Date Price: $66.15 (+1.41%)
Christopher Thomas Schott
JP Morgan Chase & Co, Research Division - Senior Analyst

Good morning, everybody. I'm Chris Schott from J.P. Morgan, and it's my pleasure to be introducing Bristol to kick off the 38th Annual J.P. Morgan Healthcare Conference. From the company, we have Giovanni Caforio, the company's Chairman and CEO.

Bristol's announced acquisition of Celgene was clearly the talk at the conference last year. With the deal now closed, very much looking forward to Giovanni's comments on the new company.

With that, turn it over to Giovanni.

Giovanni Caforio
Bristol-Myers Squibb Company - Chairman of the Board & CEO

Thank you, Chris. Good morning, everyone. It's a pleasure to be here. I do remember being here a year ago when we had just announced the acquisition of Celgene. I am actually really proud of what has happened in 2019 and how well we are positioned as a company as we start 2020.

So you will remember that -- I'm sorry, can you go back one? Thank you. You remember that last year, I discussed the value of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot